Provided by Tiger Fintech (Singapore) Pte. Ltd.

AINOS Inc.

3.29
+0.10003.13%
Post-market: 3.350.0600+1.82%16:28 EDT
Volume:60.00K
Turnover:193.62K
Market Cap:13.67M
PE:-0.42
High:3.35
Open:3.13
Low:3.07
Close:3.19
Loading ...

Ainos Inc. Announces 1-for-5 Reverse Stock Split Effective June 30, 2025

Reuters
·
02 Jul

Ainos Inc. Completes 1-for-5 Stock Consolidation to Strengthen Capital Structure and Support Growth

Reuters
·
30 Jun

Ainos Inc trading halted, news pending

TIPRANKS
·
28 Jun

Director Chun-Jung Tsai Reports Disposal of Common Shares of Ainos Inc

Reuters
·
28 Jun

Ainos Inc. Expands Strategic Partnership with ASE Technology for AI-Powered Scent Intelligence Deployment

Reuters
·
27 Jun

Ainos Plans 1-for-5 Reverse Stock Split

MT Newswires Live
·
26 Jun

Ainos Inc. Announces 1-for-5 Stock Consolidation to Enhance Institutional Appeal and Support Nasdaq Listing

Reuters
·
26 Jun

Taiwan Carbon Nano Technology Corp Reports Disposal of Common Shares of Ainos Inc

Reuters
·
26 Jun

Ainos Inc. Partners with Kenmec to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

Reuters
·
24 Jun

Director Chun-Jung Tsai Reports Disposal of Ainos Inc. Common Shares

Reuters
·
24 Jun

Ainos Inc. Reaches Key Milestones in AI Scent Technology and Clinical Trials, Reports Water Tower Research

Reuters
·
17 Jun

Ainos Inc - Veldona Oral Interferon Receives Approval to Begin Human Trials in Taiwan

THOMSON REUTERS
·
16 Jun

Ainos provides mid-year update outlining milestones

TIPRANKS
·
16 Jun

Ainos Inc. Receives Regulatory Approval in Taiwan to Begin Human Trials for VELDONA® Oral Interferon

Reuters
·
16 Jun

Ainos Inc. Achieves Breakthrough in Elderly Care with AI Nose, Targets 2026 Commercial Rollout

Reuters
·
03 Jun

Ainos Inc. Board Approves Reverse Stock Split Resolution

Reuters
·
30 May

AINOS Inc. Inks Media Partnership with New to The Street for National TV Exposure

Reuters
·
22 May

Ainos Inc. Board Approves Key Corporate Actions in Latest Meeting

Reuters
·
20 May

Ainos Inc. Announces Breakthrough Interim Results in VELDONA Clinical Trial for Feline Chronic Gingivostomatitis, Signaling New Era in Companion Animal Immunotherapy

Reuters
·
19 May

Ainos Q1 EPS $(0.21) Up From $(0.57) YoY, Sales $106.21K Up From $20.73K YoY

Benzinga
·
12 May